How Is a Cancer Treatment Plan Decided?

A cancer diagnosis does not automatically lead to one fixed treatment. Two people with the same type of cancer may receive different treatment plans because their cancer can differ in stage, molecular characteristics, overall health, previous treatment history and other important factors.

So, how is a cancer treatment plan decided?

Cancer treatment planning is a step-by-step process. A medical oncologist considers the type and stage of cancer, pathology and imaging findings, biomarkers and molecular characteristics, the patient's overall health, previous treatments and the goals of treatment. Depending on the situation, the final plan may include one treatment or a combination of chemotherapy, immunotherapy, targeted therapy, hormonal therapy, surgery and radiation therapy.

Modern oncology is increasingly moving beyond treating cancer based only on where it started. Information about the biology of an individual tumour can also help doctors identify treatments that may be appropriate for that particular cancer. This approach is commonly described as precision oncology or precision medicine.

What Factors Determine a Cancer Treatment Plan?

There is no single formula used for every cancer patient. Your oncologist brings together several pieces of information before recommending treatment.

1. The Type of Cancer

The first consideration is understanding exactly what type of cancer is present.

For example, breast cancer, lung cancer, colorectal cancer, lymphoma and leukaemia are biologically different diseases and therefore require different approaches to treatment.

Even within the same cancer type, there can be several subtypes with different biological characteristics and treatment options.

This is why the pathology or biopsy report is such an important part of cancer treatment planning. It helps establish what type of cancer is present and provides information that may influence subsequent testing and treatment decisions.

2. The Stage of Cancer

The stage describes how extensive the cancer is.

Doctors may consider the size and location of the primary tumour, involvement of nearby lymph nodes and whether the cancer has spread to distant parts of the body. Staging information helps determine the intent and sequence of treatment.

For example, treatment for a cancer that has been detected at an early stage may focus on eliminating the disease and reducing the risk of recurrence. When cancer has spread to distant organs, treatment may have different goals, such as controlling the disease, prolonging survival and maintaining quality of life.

The stage therefore plays a major role in determining which treatments are considered.

3. The Pathology and Biopsy Results

A biopsy does more than confirm that cancer is present.

Pathologists examine the cancer cells to determine their characteristics. Depending on the cancer, additional laboratory tests may be performed on the tumour tissue to identify proteins, genetic changes or other biomarkers.

These results can sometimes influence whether a particular treatment is appropriate.

Therefore, a cancer treatment plan should be based on an accurate understanding of the pathology rather than simply the location of the tumour.

4. Biomarkers and Molecular Characteristics

One of the major developments in modern cancer care is the ability to study specific characteristics of cancer cells.

Biomarker testing can examine genes, proteins and other molecules in cancer tissue or, in selected circumstances, blood. Certain biomarkers can help identify treatments that may be more likely to work for a particular cancer.

For some cancers, biomarker testing is an established part of treatment selection. In other situations, testing may be considered depending on the stage, treatment history and clinical circumstances.

This is particularly relevant when doctors are considering certain targeted therapies or immunotherapies.

It is important to remember that more testing does not automatically mean better treatment. The usefulness of a molecular test depends on the cancer, the clinical situation and whether the results can actually influence treatment decisions.

5. The Patient's Overall Health

Cancer treatment is planned for a person, not just for a tumour.

Your oncologist may consider your age, general physical condition, kidney and liver function, heart health, nutritional status, existing medical conditions, current medications and previous treatments.

These factors can influence which medicines can be used safely, the doses that may be appropriate and how treatment should be monitored.

For example, a treatment that is appropriate for one patient may require modification or an alternative approach in another patient because of an existing medical condition.

6. Previous Cancer Treatment

If you have already received treatment, your oncologist will consider what you have previously received and how your cancer responded.

This includes previous chemotherapy, radiation therapy, surgery, targeted therapy, immunotherapy or hormonal treatment where relevant.

The previous treatment history can influence the next treatment choice, particularly when cancer has returned or progressed.

Cancer treatment planning is therefore an evolving process rather than a decision that is necessarily made once and never revisited.

Is Chemotherapy Always Part of Cancer Treatment?

No.

Chemotherapy remains an important treatment for many cancers, but it is not automatically required for every cancer patient.

Chemotherapy uses medicines that kill cancer cells or stop their growth. It may be used with the goal of curing cancer, reducing the risk of recurrence, controlling cancer growth or relieving symptoms caused by cancer.

Depending on the cancer, chemotherapy may be given before surgery, after surgery, together with radiation therapy, as part of treatment for advanced disease, or in combination with other systemic treatments.

The decision to use chemotherapy depends on the individual cancer and the patient's clinical circumstances.

Learn more: [Best Centre for Chemotherapy in Surat]

When Is Immunotherapy Considered?

Immunotherapy is a type of cancer treatment that helps the immune system fight cancer. One commonly used form is immune checkpoint inhibition, which can help immune cells mount a stronger response against cancer in appropriate situations.

Immunotherapy is not suitable for every patient or every cancer.

Its potential role depends on factors such as the cancer type, stage, biomarkers and the specific treatment being considered. Some biomarker results can help doctors determine whether a patient may be more likely to benefit from particular immunotherapies.

Learn more: [Best Centre for Immunotherapy in Surat]

How Does Targeted Therapy Fit Into Treatment Planning?

Targeted therapy is designed to interfere with specific proteins or molecular changes that help cancer cells grow, divide or spread. Unlike conventional chemotherapy, which generally affects rapidly dividing cells, targeted treatments are designed around particular molecular targets.

For many targeted therapies, the tumour needs to be tested to determine whether the relevant target is present.

For example, a molecular alteration identified through biomarker testing may make a particular targeted treatment an option. However, having a biomarker does not guarantee that a treatment will work, and the final decision still depends on the complete clinical picture.

Learn more: [Best Centre for Targeted Therapy in Surat]

What Is Precision Oncology?

Precision oncology means using information about an individual patient's cancer to help guide treatment decisions.

This information can include the tumour's genes, proteins and other molecular characteristics. Precision medicine may help doctors identify treatments that are more closely matched to the biology of a particular cancer.

For example, molecular or biomarker testing may identify a genetic alteration or protein characteristic for which a targeted treatment is available.

However, precision oncology does not mean that every patient needs extensive genetic testing or that every cancer has a matching targeted drug. In many situations, established treatment approaches based on cancer type, stage and other clinical factors remain the appropriate foundation of care.

Learn more: [Precision Oncology in Surat]

Why Is the Combination of Treatments Sometimes Used?

Cancer treatment does not always involve choosing between chemotherapy, immunotherapy and targeted therapy.

In some situations, different treatments may be combined because they address different aspects of the disease.

For example, a treatment plan may involve:

Surgery → chemotherapy → radiation therapy

or

Chemotherapy + targeted therapy

or

Chemotherapy + immunotherapy

The exact sequence depends on the cancer and the clinical evidence supporting the treatment approach. Many patients receive combinations of treatments rather than a single treatment modality.

The important point is that treatment combinations should have a specific clinical rationale rather than being selected simply because more treatments are available.

What Is the Goal of Cancer Treatment?

Before deciding on treatment, your oncologist may discuss the goal of treatment.

Depending on the situation, treatment may aim to:

• Cure the cancer
• Reduce the risk of cancer returning
• Shrink a tumour before surgery or radiation
• Control cancer that has spread
• Slow cancer progression
• Relieve symptoms
• Maintain or improve quality of life

The goal can also change during the course of treatment.

For example, treatment may initially be given before surgery to shrink a tumour and make surgery more effective. In another situation, treatment may be primarily focused on controlling advanced cancer over a longer period.

Understanding the goal helps patients and families understand why a particular treatment has been recommended.

How Does an Oncologist Decide Between Different Treatment Options?

When several treatment approaches are available, the oncologist considers the evidence supporting each option alongside the individual patient's circumstances.

This may involve considering:

• Cancer type and stage
• Pathology findings
• Biomarker or molecular results
• Previous treatment
• Expected benefits
• Potential side effects
• Other health conditions
• Patient preferences and priorities
• Treatment availability
• Practical considerations related to treatment

Cancer treatment decisions are therefore both evidence-based and individualised.

A treatment that is appropriate for one patient may not necessarily be appropriate for another patient with a seemingly similar diagnosis.

Does the Treatment Plan Ever Change?

Yes.

A cancer treatment plan is not always fixed from the beginning of treatment.

Your doctor may monitor the cancer through clinical assessment, blood tests, imaging and other appropriate investigations. The response to treatment, development of side effects, changes in your health or new information about the cancer may lead to adjustments.

In some cases, treatment may be continued as planned. In others, the dose, schedule or treatment itself may need to be changed.

This ongoing assessment is an important part of modern cancer care.

What Is a Multidisciplinary Approach to Cancer Treatment?

Cancer care can involve several specialists because different aspects of treatment may require different areas of expertise.

Depending on the cancer, the care team may include a:

• Medical oncologist
• Surgical oncologist
• Radiation oncologist
• Pathologist
• Radiologist
• Genetic counsellor
• Oncology nurse
• Dietitian
• Physiotherapist
• Other supportive-care professionals

A multidisciplinary approach allows relevant specialists to consider different aspects of a patient's diagnosis and treatment.

For complex cancers, discussion among specialists can help integrate surgery, systemic treatment, radiation, pathology and molecular information into an overall treatment strategy.

What Should You Ask Your Oncologist About Your Treatment Plan?

Before starting treatment, patients may find it helpful to ask:

• What type and stage of cancer do I have?
• What is the goal of my treatment?
• What treatment options are available to me?
• Why are you recommending this particular approach?
• Do I need any additional tests before treatment?
• Is biomarker or molecular testing appropriate for my cancer?
• Will I need chemotherapy, immunotherapy or targeted therapy?
• Could more than one treatment be combined?
• What side effects should I expect?
• How will we monitor whether the treatment is working?
• How long is the treatment expected to continue?
• What should I do if I develop side effects?
• Are there any clinical trials that may be relevant to my situation?

Preparing these questions before an appointment can make it easier to understand your treatment options and participate in discussions with your healthcare team. The NCI also recommends discussing treatment options and questions with your doctor when making cancer treatment decisions.

Why Personalised Cancer Treatment Matters

Cancer is not one disease. Even cancers that begin in the same organ can behave differently because their molecular and biological characteristics can vary.

Modern cancer treatment therefore combines traditional clinical information—such as cancer type, stage and pathology—with increasingly detailed information about the tumour when that information is clinically useful.

This does not mean replacing established cancer treatments with genetic testing. Instead, precision oncology adds another layer of information when appropriate, helping doctors determine whether a particular targeted treatment, immunotherapy or other approach may be relevant.

The result is a treatment-planning process that is increasingly individualised while remaining grounded in clinical evidence.

Cancer Treatment Planning at Elite Hemat Onco Care Centre

At Elite Hemat Onco Care Centre, Surat, cancer treatment planning is centred around understanding the individual patient's diagnosis and clinical needs.

Under the guidance of Dr Kaushal Patel, Senior Medical Oncologist, treatment options may include chemotherapy, immunotherapy, targeted therapy and hormonal therapy, depending on the patient's cancer and clinical requirements.

Where clinically appropriate, treatment planning can also incorporate precision oncology, molecular testing and biomarker information to help understand whether specific treatment approaches may be relevant.

The objective is not simply to select a cancer treatment, but to develop a treatment strategy based on the patient's cancer characteristics, treatment goals, overall health and available clinical evidence.

The Bottom Line

So, how is a cancer treatment plan decided?

It starts with understanding the cancer accurately. Your oncologist considers the cancer type, stage, pathology, imaging, biomarkers and molecular characteristics where relevant, along with your overall health and previous treatment history.

From there, the treatment team considers which options may provide meaningful benefit and how they can be delivered safely.

Depending on the individual situation, the plan may involve chemotherapy, immunotherapy, targeted therapy, surgery, radiation therapy, hormonal therapy, precision oncology or a combination of treatments.

Most importantly, cancer treatment should be viewed as an individualised process rather than a one-size-fits-all prescription. Your oncologist can explain why a particular treatment has been recommended and how the plan will be monitored and adjusted throughout your cancer care journey.

Frequently Asked Questions

Is cancer treatment the same for everyone with the same cancer?

No. Treatment can differ depending on the cancer's stage, pathology, biomarkers, previous treatment, overall health and other clinical factors.

How do doctors decide whether chemotherapy is needed?

The decision depends on the cancer type, stage, treatment goal, previous treatment and other individual factors. Chemotherapy may be used alone or alongside other treatments.

Does every cancer patient need molecular testing?

No. The usefulness of biomarker or molecular testing depends on the type of cancer and the clinical situation. Your oncologist can determine whether testing is likely to influence treatment decisions.

What is the difference between targeted therapy and chemotherapy?

Chemotherapy generally acts against rapidly dividing cells, whereas targeted therapy is designed to act on specific molecular targets involved in cancer growth and spread. Targeted therapy often requires testing to determine whether the relevant target is present.

Is immunotherapy suitable for every cancer?

No. Immunotherapy is useful for selected cancers and clinical situations. Its potential benefit can depend on the cancer type and, for some treatments, relevant biomarkers.

Can a cancer treatment plan change after treatment starts?

Yes. Treatment may be modified depending on treatment response, side effects, changes in health or new clinical information. Your oncologist monitors your progress and determines whether the treatment plan should continue or change.

What does precision oncology mean?

Precision oncology uses information about an individual tumour—including relevant molecular and biomarker information—to help guide cancer treatment decisions.

Medical Disclaimer: This article is intended for general educational purposes and does not replace personalised medical advice. Cancer treatment decisions depend on the individual diagnosis, stage, pathology, molecular characteristics, overall health and other clinical factors. Please consult a qualified cancer specialist for advice regarding your specific condition.

‍